비교리스트

 카트 문의
시장보고서
상품코드
1373928

세계의 알파 이미터 시장 : 방사성 핵종별, 용도별, 최종 사용자별, 국가별, 지역별-산업 분석, 시장 규모, 시장 점유율 및 예측(2023-2030년)

Alpha Emitter Market, By Type of Radionuclide, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 311 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

알파 이미터(Alpha Emitter) 시장 규모는 2022년에 4억 1,687만 달러로 평가되어 2023년부터 2030년에 걸쳐 CAGR 12.6%로 추이하며 성장 할 것으로 예상됩니다.

치료에는 특수 항염증제의 투여와 폐의 공기 통로를 넓히는 것을 목표로 한 혁신적인 기관지 확장술이 포함됩니다. 다른 혜택으로, 증상의 심각성을 줄이고 악화를 예방하는 데 중요한 역할을하는 점액 클리어런스를 촉진하기 위해 고안된 표적 약물이 종종 환자에게 효과적입니다. 치료 계획은 증상 관리, 재연 예방, 폐 기능 최적화에 주목하면서 각 환자의 구체적인 요구 사항에 맞게 면밀히 만들어집니다. 기관지 천식을 다루는이 종합적인 접근법을 통해 환자는 호흡기 시스템의 건강을 개선하고 더 풍부한 삶을 살 수 있습니다.

알파 이미터 시장-시장 역학

과소 진단되기 쉬운 질병에 대한 인식이 높아짐에 따라 시장 수요를 촉진

의학적 지식과 진단 도구의 진보로 기관지 확장증에 대한 인식이 높아지고 있습니다. 또한 인구 역학의 고령화와 만성 호흡기 질환의 급증으로 더욱 효과적인 치료법에 대한 수요가 높아지고 있습니다. 이러한 인식 증가와 환자 수 증가는 제약 회사와 연구자를 혁신적인 의약품 개발을 포함한 기관지 확장증 치료를위한 선구적인 솔루션에 투자하기 위해 노력하고 있습니다. 이러한 노력의 극히 중요한 원동력이 되고 있는 것은 기관지확장증 환자의 생활의 질을 향상시켜, 재발하는 증상이나 감염증의 부담을 경감시킨다는 추구입니다.

알파 이미터 시장-주요 통찰

우리의 조사 분석가들의 평가에 따르면 세계 알파 이미터 산업은 2023년부터 2030년까지의 예측 기간 동안 약 12.6%의 연간 성장률을 전망하고 있습니다.

알파 이미터 분야는 종종 과소 진단되는 상태의 인식 증가가 주요 요인이되어 큰 확대가 예상됩니다.

방사성 핵종 범주에서 라듐(Ra-223)은 2022년에 가장 높은 시장 점유율을 보였습니다.

용도별로는 골전이가 2022년 최상위 자리를 차지합니다.

지역별로 북미는 2022년 주요 수익원으로 부상했습니다.

알파 이미터 시장-세분화 분석 :

알파 이미터 시장은 방사성 핵종 유형, 용도, 최종 사용자 및 지역을 종합적으로 세분화합니다.

방사성 핵종 유형를 고려하면, 시장은 6가지의 다른 카테고리로 나뉩니다 : 라듐(Ra-223), 악티늄(Ac-225), 납(Pb-212), 아스타틴-211, 비스무트-213, 등입니다. 주목할 점은 라듐(Ra-223)이 이 세분화에서 선도하고 있다는 것입니다. 라듐 223(Ra-223)은 표적 알파 입자 요법, 특히 전이성 전립선 암의 치료에 있어서 그 효능에 의해 매우 인기 있는 방사성 핵종으로서 두드러집니다. 근방의 건강한 세포를 보호하면서 암성 골 조직을 특이적으로 표적으로 하는 그 현저한 능력은 뼈로 전이한 진행성 전립선암 환자의 QOL과 생존율의 향상에 크게 기여하고 있다 합니다.

알파 이미터 시장-지리적 통찰

지리적 관점에서 이 시장은 북미, 남미, 유럽, 아시아 태평양, 중동, 아프리카 등 폭넓은 지역을 망라하고 있습니다. 이 지역은 개별 국가로 나뉘어져 있으며 각각은 비즈니스 전망에 기여합니다.

북미는 암 치료와 핵의학에서 알파선 방출장치의 중요한 역할로부터 알파선방출장치의 중요한 거점으로 두드러지고 있습니다. 표적을 좁힌 알파 입자 방사에서 알파 방출 동위 원소의 이용은 암 치료에 대한 혁신적인 접근이며, 다양한 유형의 암에 대처할 수 있는 큰 가능성을 가지고 있습니다.

알파 이미터 시장-경쟁 구도 :

알파 이미터 분야에서는 핵의학과 방사성 의약품을 전문으로 하는 수많은 유명한 기업의 존재로 경쟁 구도가 특징입니다. Actinium Pharmaceuticals, Curium, Lantheus Holdings 등 산업를 선도하는 기업은 의료용 알파선 방출 동위 원소의 탐색과 생산에 적극적인 역할을 하고 있습니다. 또한, 신흥기업과 연구기관이 알파선 방출핵종을 이용한 독창적인 의약품 및 진단 툴의 개발에 적극적으로 기여하고 있는 것도 경쟁의 배경에 영향을 미치고 있습니다.

목차

제1장 알파 이미터 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 알파 이미터의 주요 시장 동향

  • 시장 성장 촉진 요인
  • 시장 성장 억제 요인
  • 시장 기회
  • 향후 시장 동향

제4장 알파 이미터 산업의 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 맵핑
  • 규제 틀 분석

제5장 알파 이미터 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 후의 영향 분석

제6장 알파 이미터 시장 상황

  • 알파 이미터 시장 점유율 분석(2022년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 알파 이미터 시장-방사성 핵종별

  • 개요
    • 방사성 핵종별 부문 점유율 분석
    • 라듐(Ra-223)
    • 악티늄(Ac-225)
    • 납(Pb-212)
    • 아스타틴-211
    • 비스무트-213
    • 기타

제8장 알파 이미터 시장-용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 골전이
    • 전립선암
    • 신경 내분비 종양
    • 난소암
    • 기타

제9장 알파 이미터 시장-최종 사용자별

  • 개요
    • 최종 사용자별 부문 점유율 분석
    • 병원
    • 전문 클리닉
    • 진단센터
    • 기타

제10장 알파 이미터 시장-지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아 태평양(APAC)
    • 개요
    • 아시아 태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 남미
    • 개요
    • 남미의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석-알파 이미터 산업

  • 경쟁 대시보드
  • 기업 개요
    • Actinium Pharmaceutical Inc.
    • Alpha Tau Medical Ltd
    • Bayer AG
    • Bracco
    • Cardinal Health
    • Eckert&Ziegle
    • Fusion Pharmaceuticals
    • IBA Worldwide
    • NorthStar Medical Radioisotopes(NMR)
    • Orano Group
    • Viewpoint Molecular Targeting
    • RadioMedix
    • Telix Pharmaceuticals Limited.
    • TerraPower, LLC
    • NIOWAVE Inc.
    • IONETIX Corporation.

제12장 애널리스트의 전방위 전망

LYJ 23.11.13

REPORT HIGHLIGHT

Alpha Emitter Market size was valued at USD 416.87 Million in 2022, expanding at a CAGR of 12.6% from 2023 to 2030.

Alpha emitter medicines have proven effective in addressing the challenges of a rare autoimmune disorder known as "Bronchial Blaze." This condition is characterized by the abnormal inflammation and constriction of the bronchial tubes, which can result in debilitating symptoms such as persistent breathlessness, chronic coughing, and frequent pulmonary flare-ups. The treatment regimen for Bronchial Blaze involves a multifaceted approach tailored to the individual needs of each patient. This approach prioritizes alleviating symptoms, minimizing the risk of recurring episodes, and enhancing overall lung function to enhance the quality of life for those afflicted by this condition.

Therapies may include the administration of specialized anti-inflammatory agents, as well as innovative bronchodilation techniques aimed at expanding the air passages within the lungs. Additionally, patients often benefit from targeted medications designed to promote mucus clearance, which plays a crucial role in reducing the severity of symptoms and preventing exacerbations. The treatment plan is meticulously crafted to cater to each patient's specific requirements, with a primary focus on symptom management, prevention of flare-ups, and the optimization of lung function. This comprehensive approach to addressing Bronchial Blaze ensures that affected individuals can lead more fulfilling lives with improved respiratory health.

Alpha Emitter Market- Market Dynamics

Rising awareness of this often-underdiagnosed condition propel market demand

With advancements in medical knowledge and diagnostic tools, there is a growing recognition of bronchiectasis cases. Additionally, an aging demographic and the surge in chronic respiratory conditions have amplified the demand for more effective treatments. This heightened awareness and the expanding patient population have spurred pharmaceutical companies and researchers to invest in pioneering solutions for bronchiectasis care, including the development of innovative pharmaceuticals. A pivotal driving force behind these efforts is the quest to enhance the quality of life for bronchiectasis patients, lessening the burden of recurrent symptoms and infections.

Alpha Emitter Market- Key Insights

According to our research analyst's assessment, the global Alpha Emitter industry anticipates an annual growth rate of approximately 12.6% throughout the forecast period spanning from 2023 to 2030.

The Alpha Emitter sector is poised for substantial expansion, largely driven by the increasing recognition of a condition that often goes underdiagnosed.

Within the Radionuclide category, Radium (Ra-223) is expected to exhibit the most significant market share in the year 2022.

In terms of application breakdown, Bone Metastases claimed the top position among Radionuclide types in 2022.

Geographically, North America emerged as the primary source of revenue generation in the year 2022.

Alpha Emitter Market- Segmentation Analysis:

The Global Alpha Emitter Market exhibits a comprehensive segmentation, which encompasses Type of Radionuclide, Application, End User, and Region.

When considering the Type of Radionuclide, the market branches into six distinct categories: Radium (Ra-223), Actinium (Ac-225), Lead (Pb-212), Astatine-211, Bismuth-213, and Others. Notably, Radium (Ra-223) takes the lead in this segmentation. Radium-223 (Ra-223) stands out as a highly sought-after radionuclide due to its effectiveness in targeted alpha-particle therapy, particularly in the treatment of metastatic prostate cancer. Its remarkable ability to specifically target cancerous bone tissue while safeguarding healthy cells in the vicinity contributes significantly to improving the quality of life and survival rates for patients dealing with advanced prostate cancer that has spread to the bones.

Alpha Emitter Market- Geographical Insights

From a geographical perspective, this market encompasses a wide range of regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further subdivided into individual countries, each contributing to the business landscape.

North America stands out as a significant hub for Alpha emitters due to their crucial role in cancer therapy and nuclear medicine. The utilization of alpha-emitting isotopes in targeted alpha-particle radiation represents an innovative approach to cancer treatment, holding great potential for addressing a variety of cancer types.

Alpha Emitter Market- Competitive Landscape:

The arena of alpha emitters presents a competitive landscape marked by the presence of numerous prominent companies specializing in nuclear medicine and radiopharmaceuticals. Established industry leaders such as Actinium Pharmaceuticals, Curium, and Lantheus Holdings play active roles in the exploration and production of alpha-emitting isotopes for medical applications. Furthermore, the competitive backdrop is influenced by the contributions of startups and research institutions, as they actively contribute to the development of inventive pharmaceuticals and diagnostic tools based on alpha emitters.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ALPHA EMITTER MARKET KEY PLAYERS

  • Actinium Pharmaceutical Inc.
  • Alpha Tau Medical Ltd
  • Bayer AG
  • Bracco
  • Cardinal Health
  • Eckert & Ziegle
  • Fusion Pharmaceuticals
  • IBA Worldwide
  • NorthStar Medical Radioisotopes (NMR)
  • Orano Group
  • Viewpoint Molecular Targeting
  • RadioMedix
  • Telix Pharmaceuticals Limited.
  • TerraPower, LLC
  • NIOWAVE Inc.
  • IONETIX Corporation

GLOBAL ALPHA EMITTER MARKET, BY TYPE OF RADIONUCLIDE

  • Radium (Ra-223)
  • Actinium (Ac-225)
  • Lead (Pb-212)
  • Astatine-211
  • Bismuth-213
  • Others

GLOBAL ALPHA EMITTER MARKET, BY APPLICATION

  • Bone Metastases
  • Prostate Cancer
  • Neuroendocrine Tumors
  • Ovarian Cancer
  • Others

GLOBAL ALPHA EMITTER MARKET, BY END USER

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Others

GLOBAL ALPHA EMITTER MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Alpha Emitter Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Alpha Emitter Market Snippet by Type of Radionuclide
    • 2.1.2. Alpha Emitter Market Snippet by Application
    • 2.1.3. Alpha Emitter Market Snippet by End User
    • 2.1.4. Alpha Emitter Market Snippet by Country
    • 2.1.5. Alpha Emitter Market Snippet by Region
  • 2.2. Competitive Insights

3. Alpha Emitter Key Market Trends

  • 3.1. Alpha Emitter Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Alpha Emitter Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Alpha Emitter Market Opportunities
  • 3.4. Alpha Emitter Market Future Trends

4. Alpha Emitter Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Alpha Emitter Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Alpha Emitter Market Landscape

  • 6.1. Alpha Emitter Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Alpha Emitter Market - By Type of Radionuclide

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type of Radionuclide, 2022 & 2030 (%)
    • 7.1.2. Radium (Ra-223)
    • 7.1.3. Actinium (Ac-225)
    • 7.1.4. Lead (Pb-212)
    • 7.1.5. Astatine-211
    • 7.1.6. Bismuth-213
    • 7.1.7. Others

8. Alpha Emitter Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Bone Metastases
    • 8.1.3. Prostate Cancer
    • 8.1.4. Neuroendocrine Tumors
    • 8.1.5. Ovarian Cancer
    • 8.1.6. Others

9. Alpha Emitter Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Specialty Clinics
    • 9.1.4. Diagnostic Centers
    • 9.1.5. Others

10. Alpha Emitter Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Alpha Emitter Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Alpha Emitter Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Alpha Emitter Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Alpha Emitter Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Alpha Emitter Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type of Radionuclide, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Alpha Emitter Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Actinium Pharmaceutical Inc.
    • 11.2.2. Alpha Tau Medical Ltd
    • 11.2.3. Bayer AG
    • 11.2.4. Bracco
    • 11.2.5. Cardinal Health
    • 11.2.6. Eckert & Ziegle
    • 11.2.7. Fusion Pharmaceuticals
    • 11.2.8. IBA Worldwide
    • 11.2.9. NorthStar Medical Radioisotopes (NMR)
    • 11.2.10. Orano Group
    • 11.2.11. Viewpoint Molecular Targeting
    • 11.2.12. RadioMedix
    • 11.2.13. Telix Pharmaceuticals Limited.
    • 11.2.14. TerraPower, LLC
    • 11.2.15. NIOWAVE Inc.
    • 11.2.16. IONETIX Corporation.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제